OASM News
Archived Headlines
- US IPO Weekly Recap: Year's largest IPO First Data raises $2.6 billion and falls flat 10/16/15
- Microcap IPOs on tap in coming weeks; several billion-dollar IPOs could follow 09/18/15
- Swedish cancer biotech Oasmia Pharmaceutical narrows range for IPO 09/15/15
- Swedish cancer biotech Oasmia Pharmaceutical files for a $23 million US IPO 07/06/15
US IPO Weekly Recap: Paper gains for a paper packaging producer
Pricing pressure continued this week as only one company was able to price in or above its range. Five IPOs raised $1.2 billion this week, including one of the most highly-anticipated IPOs of 2015. However, it was a global print packaging...read more
Swedish cancer biotech Oasmia Pharmaceutical prices IPO at $4.06, below the range
Oasmia Pharmaceutical, which is developing new formulations of existing chemotherapy drugs for use in humans and dogs, raised $9 million by offering 2.3 million ADSs at $4.06, below the range of $4.70 to $6.70. The offering also included 1.1 million warrants...read more
Oasmia Pharmaceutical decreases proposed IPO deal size
Oasmia Pharmaceutical, which is developing formulations of widely-used cancer drugs for humans and dogs, lowered the proposed deal size for its upcoming IPO on Monday. The Uppsala, Sweden-based company decreased the proposed maximum aggregate offering...read more
Week ahead: One of the most highly-anticipated IPOs of 2015
A still fragile US IPO market will look to continue to find its footing this week. Companies have experienced significant pricing pressure in the last few weeks, with 11 out of the last 13 IPOs pricing below the range. Next week, a...read more